Kari Laine - UTU Research Portal - UTU Research Portal

Kari Laine

- Docent,
Faculty of Medicine (University of Turku)

karlai@utu.fi

Development and pilot testing of PHARAO—a decision support system for pharmacological risk assessment in the elderly (2018)
- European Journal of Clinical Pharmacology
Andersson M., Böttiger Y., Laine K., Korhonen T., Lähdesmäki J., Shemeikka T., Julander M., Edlert M.
Voriconazole greatly increases the exposure to oral buprenorphine (2018)
- European Journal of Clinical Pharmacology
Mari Fihlman, Tuija Hemmilä, Nora M. Hagelberg, Janne T. Backman, Jouko Laitila, Kari Laine, Pertti J. Neuvonen, Klaus T. Olkkola, Teijo I. Saari
Identifying high risk medications causing potential drug-drug interactions in outpatients: A prescription database study based on an online surveillance system (2016)
- Research in Social and Administrative Pharmacy
T.M.Toivo, J.A.V. Mikkola, K. Laine, M. Airaksinen
Rifampicin decreases exposure to sublingual buprenorphine in healthy subjects (2016)
- Pharmacology Research and Perspectives
Hagelberg Nora M, Fihlman M, Hemmilä Tuija, Backman Janne T, Neuvonen Pertti J, Laine Kari, Olkkola Klaus T, Saari Teijo
Voriconazole more likely than posaconazole increases plasma exposure to sublingual buprenorphine causing a risk of a clinically important interaction (2016)
- European Journal of Clinical Pharmacology
Fihlman M, Hemmila T, Hagelberg NM, Kuusniemi K, Backman JT, Laitila J, Laine K, Neuvonen PJ, Olkkola KT, Saari TI
Effects of terbinafine and itraconazole on the pharmacokinetics of orally administered tramadol (2015)
- European Journal of Clinical Pharmacology
Saarikoski T, Saari TI, Hagelberg NM, Backman JT, Neuvonen PJ, Scheinin M, Olkkola KT, Laine K
The degree of fetal metformin exposure does not influence fetal outcome in gestational diabetes mellitus (2014)
- Acta Diabetologica
Kristiina Tertti, Kari Laine, Ulla Ekblad, Valtteri Rinne, Tapani Rönnemaa
Epidemiology of CYP3A4-Mediated Clopidogrel Drug-Drug Interactions and Their Clinical Consequences (2013)
- Cardiovascular Therapeutics
Tirkkonen T, Heikkila P, Vahlberg T, Huupponen R, Laine K
Rifampicin has a Profound Effect on the Pharmacokinetics of Oral S-Ketamine and Less on Intravenous S-Ketamine (2012)
- Basic and Clinical Pharmacology and Toxicology. Supplement
Peltoniemi MA, Saari TI, Hagelberg NM, Laine K, Kurkinen KJ, Neuvonen PJ, Olkkola KT
S-ketamine concentrations are greatly increased by grapefruit juice (2012)
- European Journal of Clinical Pharmacology
Peltoniemi MA, Saari TI, Hagelberg NM, Laine K, Neuvonen PJ, Olkkola KT
St John's wort greatly decreases the plasma concentrations of oral S-ketamine (2012)
- Fundamental and Clinical Pharmacology
Peltoniemi MA, Saari TI, Hagelberg NM, Laine K, Neuvonen PJ, Olkkola KT
Effect of Inhibition of Cytochrome P450 Enzymes 2D6 and 3A4 on the Pharmacokinetics of Intravenous Oxycodone A Randomized, Three-Phase, Crossover, Placebo-Controlled Study (2011)
- Clinical Drug Investigation
Gronlund J, Saari TI, Hagelberg NM, Neuvonen PJ, Laine K, Olkkola KT
Exposure to Oral S-ketamine Is Unaffected by Itraconazole but Greatly Increased by Ticlopidine (2011)
- Clinical Pharmacology and Therapeutics
Peltoniemi MA, Saari TI, Hagelberg NM, Reponen P, Turpeinen M, Laine K, Neuvonen PJ, Olkkola KT
Miconazole Oral Gel Increases Exposure to Oral Oxycodone by Inhibition of CYP2D6 and CYP3A4 (2011)
- Antimicrobial Agents and Chemotherapy
Gronlund J, Saari TI, Hagelberg N, Neuvonen PJ, Olkkola KT, Laine K
Potential CYP2C9-mediated drug-drug interactions in hospitalized type 2 diabetes mellitus patients treated with the sulphonylureas glibenclamide, glimepiride or glipizide (2010)
- Journal of Internal Medicine
Tirkkonen T, Heikkilä P, Huupponen R, Laine K